Login to Your Account

Financings NEWS

Theravance Biopharma Inc. priced an upsized $94.1 million public offering on Friday, saying it would sell about 4.77 million shares at $21 each as it moves to build a strong balance sheet capable of supporting two key development programs.

LONDON – The U.S. technology commercialization specialist Allied Minds plc has raised $80 million from U.K. investors to fund drug discovery programs in-licensed through its partnership with Bristol-Myers Squibb Co.

SHANGHAI – Hua Medicine Ltd. has raised $50 million in a series C investment led by China-based Harvest Investments. Hua is now preparing a phase III trial for its lead candidate, HMS5552.

More Financings Headlines

Cast Your Vote

Should there be restrictions on the use of gene-editing technology?: